The decision comes after weeks of debate over whether or not Covid-19 vaccine third doses are needed
by Nicole Wetsman | Sep 22, 2021, 7:59 pm EDT | The Verge | COVID-19 vaccine
The Food and Drug Administration cleared a third dose of the Pfizer / BioNTech COVID-19 vaccine for people some vulnerable groups — the first booster in the United States’ vaccination efforts.
The agency signed off on boosters for people 65 years of age and older, those who are at high risk of severe disease, health care workers, and other people at high risk of exposure to COVID-19 at work.
Click here for the rest of the story…
